SK284974B6 - Medziprodukty na výrobu a spôsob výroby proteázového inhibítora - Google Patents
Medziprodukty na výrobu a spôsob výroby proteázového inhibítora Download PDFInfo
- Publication number
- SK284974B6 SK284974B6 SK226-2000A SK2262000A SK284974B6 SK 284974 B6 SK284974 B6 SK 284974B6 SK 2262000 A SK2262000 A SK 2262000A SK 284974 B6 SK284974 B6 SK 284974B6
- Authority
- SK
- Slovakia
- Prior art keywords
- acid
- formula
- cvi
- hydroxylactone
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5861897P | 1997-09-11 | 1997-09-11 | |
| PCT/US1998/017993 WO1999012919A1 (en) | 1997-09-11 | 1998-09-03 | Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK2262000A3 SK2262000A3 (en) | 2000-10-09 |
| SK284974B6 true SK284974B6 (sk) | 2006-03-02 |
Family
ID=22017924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK226-2000A SK284974B6 (sk) | 1997-09-11 | 1998-09-03 | Medziprodukty na výrobu a spôsob výroby proteázového inhibítora |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6077963A (cs) |
| EP (1) | EP1015441B1 (cs) |
| JP (3) | JP4462760B2 (cs) |
| KR (1) | KR100569771B1 (cs) |
| CN (3) | CN1298714C (cs) |
| AT (1) | ATE266654T1 (cs) |
| CA (1) | CA2300204C (cs) |
| CZ (1) | CZ298847B6 (cs) |
| DE (1) | DE69823844T2 (cs) |
| DK (1) | DK1015441T3 (cs) |
| ES (1) | ES2221199T3 (cs) |
| FI (1) | FI120973B (cs) |
| HU (1) | HU228986B1 (cs) |
| NO (1) | NO321835B1 (cs) |
| NZ (1) | NZ503338A (cs) |
| PL (1) | PL193240B1 (cs) |
| PT (1) | PT1015441E (cs) |
| RU (2) | RU2223958C2 (cs) |
| SK (1) | SK284974B6 (cs) |
| WO (1) | WO1999012919A1 (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60000660T2 (de) | 1999-03-18 | 2003-06-26 | Pharmacia & Upjohn Co., Kalamazoo | Verbesserte verfahren fur assymmetrische hydrogenation |
| US6552204B1 (en) * | 2000-02-04 | 2003-04-22 | Roche Colorado Corporation | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
| DE10108470A1 (de) * | 2001-02-22 | 2002-09-05 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung optisch aktiver Dihydropyrone |
| US6500963B2 (en) | 2001-02-22 | 2002-12-31 | Boehringer Ingelheim Pharma Kg | Process for preparing optically active dihydropyrones |
| US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| CN1301244C (zh) | 2002-02-07 | 2007-02-21 | 住友化学工业株式会社 | 生产(r)－3－羟基－3－(2－苯基乙基)己酸及其中间体的方法 |
| DE10313118A1 (de) * | 2003-03-24 | 2004-10-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese |
| US7512945B2 (en) * | 2003-12-29 | 2009-03-31 | Intel Corporation | Method and apparatus for scheduling the processing of commands for execution by cryptographic algorithm cores in a programmable network processor |
| CN100448836C (zh) * | 2005-06-03 | 2009-01-07 | 浙江中贝化工有限公司 | 一种抗艾滋病药物关键中间体的制备方法 |
| WO2007023381A1 (en) * | 2005-08-24 | 2007-03-01 | Pfizer Inc. | Methods for the preparation of hcv polymerase inhibitors |
| EP2232608B1 (en) * | 2007-11-30 | 2018-08-15 | Semiconductor Energy Laboratory Co, Ltd. | Light-emitting element, light-emitting device, and electronic device |
| EP2617706B1 (en) * | 2011-07-29 | 2017-09-06 | Anhui New Star Pharmaceutical Development Co., Ltd | Novel intermediate used for preparing tapentadol or analogues thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1355667A (fr) * | 1963-02-05 | 1964-03-20 | Meci Materiel Elect Contr | Gaine tubulaire pour électrode servant à la mesure du ph |
| FR1355668A (fr) * | 1963-02-05 | 1964-03-20 | Moteur rotatif à combustion interne perfectionné | |
| FR2096877B1 (cs) * | 1970-07-09 | 1973-08-10 | Hexachimie | |
| JPH0665657B2 (ja) * | 1984-11-08 | 1994-08-24 | 日本化薬株式会社 | 光学活性マンデル酸の製法 |
| JPH072677B2 (ja) * | 1988-02-19 | 1995-01-18 | 株式会社クラレ | （±）―２―ヒドロキシ―４―フェニルブタン酸の光学分割法 |
| JPH01221345A (ja) * | 1988-02-27 | 1989-09-04 | Ajinomoto Co Inc | マンデル酸誘導体の光学分割方法 |
| JP3084577B2 (ja) * | 1991-09-27 | 2000-09-04 | 山川薬品工業株式会社 | 光学活性なアトロラクチン酸の製造方法および製造の中間体 |
| JP3178086B2 (ja) * | 1992-06-17 | 2001-06-18 | 山川薬品工業株式会社 | 光学活性α−メチルベンジルアミンの製造方法 |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| EP0729464A1 (en) * | 1993-11-19 | 1996-09-04 | PARKE, DAVIS & COMPANY | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
| RU2074169C1 (ru) * | 1995-05-10 | 1997-02-27 | Акционерное общество открытого типа "Химпром" | Способ получения этилового эфира п-нитробензойной кислоты |
-
1998
- 1998-09-03 JP JP2000510727A patent/JP4462760B2/ja not_active Expired - Lifetime
- 1998-09-03 DK DK98945806T patent/DK1015441T3/da active
- 1998-09-03 EP EP98945806A patent/EP1015441B1/en not_active Expired - Lifetime
- 1998-09-03 KR KR1020007002546A patent/KR100569771B1/ko not_active Expired - Lifetime
- 1998-09-03 DE DE69823844T patent/DE69823844T2/de not_active Expired - Lifetime
- 1998-09-03 CN CNB988087111A patent/CN1298714C/zh not_active Expired - Lifetime
- 1998-09-03 CZ CZ20000804A patent/CZ298847B6/cs not_active IP Right Cessation
- 1998-09-03 CN CNB031594735A patent/CN1284763C/zh not_active Expired - Lifetime
- 1998-09-03 CA CA002300204A patent/CA2300204C/en not_active Expired - Lifetime
- 1998-09-03 HU HU0003593A patent/HU228986B1/hu unknown
- 1998-09-03 NZ NZ503338A patent/NZ503338A/en not_active IP Right Cessation
- 1998-09-03 ES ES98945806T patent/ES2221199T3/es not_active Expired - Lifetime
- 1998-09-03 CN CNB2007100079776A patent/CN100471832C/zh not_active Expired - Lifetime
- 1998-09-03 SK SK226-2000A patent/SK284974B6/sk not_active IP Right Cessation
- 1998-09-03 AT AT98945806T patent/ATE266654T1/de active
- 1998-09-03 WO PCT/US1998/017993 patent/WO1999012919A1/en active IP Right Grant
- 1998-09-03 RU RU2000109277/04A patent/RU2223958C2/ru active
- 1998-09-03 PT PT98945806T patent/PT1015441E/pt unknown
- 1998-09-03 PL PL339138A patent/PL193240B1/pl unknown
- 1998-12-17 US US09/213,887 patent/US6077963A/en not_active Expired - Lifetime
-
2000
- 2000-02-28 US US09/514,087 patent/US6265604B1/en not_active Expired - Lifetime
- 2000-03-10 NO NO20001274A patent/NO321835B1/no not_active IP Right Cessation
- 2000-03-10 FI FI20000553A patent/FI120973B/fi not_active IP Right Cessation
-
2003
- 2003-10-21 RU RU2003131081/04A patent/RU2263106C2/ru active
-
2009
- 2009-02-03 JP JP2009022289A patent/JP5016621B2/ja not_active Expired - Lifetime
- 2009-12-10 JP JP2009280318A patent/JP5266194B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5266194B2 (ja) | プロテアーゼインヒビターとして有用な４−ヒドロキシ−２−オキソ−ピラン誘導体の製法 | |
| FR2473519A1 (fr) | Terpenoides contenant deux groupes fonctionnels, leur preparation et leur application therapeutique | |
| AU743496C (en) | Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors | |
| WO2002022618A1 (fr) | Preparation de la camptothecine et de ses derives | |
| FR2615735A1 (fr) | Compositions therapeutiques a base de nouveaux (o-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes | |
| MXPA00002411A (en) | Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors | |
| FR2615855A1 (fr) | Nouveaux methoxy-5 alcoyl ammonium tetrahydrofuranes et tetrahydrothiophenes ainsi que leur procede de preparation | |
| FR2595350A1 (fr) | Procede de couplage biarylique, catalyseur au ruthenium pour sa mise en oeuvre et nouveaux composes en resultant | |
| EP0818447B1 (de) | 6-(Hydroxymethyl-ethyl)pyridine als HMG-CoA-Reduktase Inhibitoren | |
| HK1104027B (en) | Compounds useful to produce a protease inhibitor | |
| HK1030418B (en) | Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors | |
| JPS62111966A (ja) | （±）−パニクリジンｂの製造方法 | |
| FR2794123A1 (fr) | Preparation de derives de la camptothecine et de la nothapodytine | |
| HK1063776B (en) | Compounds usefull to produce a protease inhibitors | |
| EP0282897A2 (de) | Aethinyl- und Aethenyl-Styryl-ketone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Expiry of patent |
Expiry date: 20180903 |